Loading
Latest filing published 18 Feb 2026 for Corbus Pharmaceuticals Holdings, Inc., €5,277.
Ian Hodgson appears in our data through filings on Corbus Pharmaceuticals Holdings, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 14 January 2026 to 17 February 2026.
On the market, this insider has only sold: 2 sales, €22k in total. Other entries cover 1 share grant.
The newest entry dates from 18 February 2026: an open-market sale of €5,277, in Corbus Pharmaceuticals Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations